[2-(methacryloyloxy)ethyl]triethylammonium bromide

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: [2-(methacryloyloxy)ethyl]triethylammonium bromide
• 英文别名: N,N,N-triethyl-N-[2-(methacryloyloxy)ethyl]ammonium bromide；2-methacryloyl-oxyethyl-N,N,N-triethyl-ammonium bromide；triethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;bromide
• 化学式: Br*C₁₂H₂₄NO₂
• 分子量: 294.232
• InChiKey: UWEUSLOBLWDWOU-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.01
• 重原子数：
  16
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  溴乙烷 、 甲基丙烯酸二乙氨基乙酯 以 丙酮 为溶剂， 反应 144.0h， 以60.8%的产率得到[2-(methacryloyloxy)ethyl]triethylammonium bromide
  参考文献：
  名称：

  用于固态聚合物电解质的可聚合离子液体。

  摘要：

  合成了八种新型可聚合铵-TFSI离子液体，并针对其在储能设备中的应用进行了表征。离子液体具有甲基丙烯酸酯或丙烯酸酯末端作为可聚合基团的特征。优化了制剂以高产率获得前体和离子液体。所有产物均通过NMR和IR光谱表征。通过DSC分析获得相变温度。比较并讨论了离子液体的密度，粘度和离子电导率。结果表明，在可聚合官能团上连接的烷基的长度以及甲基的长度对离子液体的物理化学性质有重大影响。在25°C下，[C 2 NA，22] TFSI的离子电导率值在0.264 mS cm-1和[C = NMA，22] TFSI的0.080 mS cm-1之间。

  DOI：

  10.3390/molecules24020324

文献信息

• On the Use of Polyelectrolytes and Polymediators in Organic Electrosynthesis
  作者：Benjamin Schille、Niels Ole Giltzau、Robert Francke

  DOI：10.1002/anie.201710659

  日期：2018.1.8

  Although organic electrosynthesis is generally considered to be a green method, the necessity for excess amounts of supporting electrolyte constitutes a severe drawback. Furthermore, the employment of redox mediators results in an additional separation problem. In this context, we have explored the applicability of soluble polyelectrolytes and polymediators with the TEMPO‐mediated transformation of

  尽管通常认为有机电合成是一种绿色方法，但是过量支持电解质的必要构成了严重的缺点。此外，使用氧化还原介体导致另外的分离问题。在这种情况下，我们已经探索了将可溶性聚电解质和聚介体与TEMPO介导的醇转化为羰基化合物作为测试反应的适用性。基于循环伏安法研究的催化剂基准测试表明，氧化还原活性聚合物可以与分子定义的TEMPO种类竞争。酒精氧化在制备规模上也非常高效，我们基于聚合物的方法允许在单个膜过滤步骤中分离介体和支持电解质。而且，
• Leukocyte-removing filter and leukocyte-removing apparatus furnished therewith
  申请人：TERUMO KABUSHIKI KAISHA

  公开号：EP0500472A2

  公开（公告）日：1992-08-26

  A filter for removing leukocytes and thrombocytes from a solution containing blood components, such as CRC- comprises a filter material having a surface on which zeta potential is a positive value in an electrolyte solution having a pH value of 5.0 to 7.0. In a case where the filter material originally has a negative zeta potential, the filter material to be used in the filter is pretreated so that zeta potential thereon becomes a positive value in an electrolyte solution having pH value of 5.0 to 7.0.

  一种用于从含有血液成分（如 CRC）的溶液中去除白细胞和血小板的过滤器包括一种过滤材料，其表面的 zeta 电位在 pH 值为 5.0 至 7.0 的电解质溶液中为正值。如果过滤材料原本的 zeta 电位为负值，则要对过滤器中使用的过滤材料进行预处理，使其在 pH 值为 5.0 至 7.0 的电解质溶液中的 zeta 电位变为正值。
• METAL MEDICAL DEVICE
  申请人：SUMITOMO RUBBER INDUSTRIES, LTD.

  公开号：EP2992909A1

  公开（公告）日：2016-03-09

  The present invention provides metal medical devices which are provided with sliding properties (lubricity), low protein adsorption properties and low cell adsorption properties and further in which these properties are prevented from deteriorating. The present invention relates to a metal medical device having a surface at least partially treated with a copolymer C of a polymerizable silane compound A and a polymerizable compound B that contains a functional group.

  本发明提供的金属医疗器械具有滑动性能（润滑性）、低蛋白吸附性能和低细胞吸附性能，并能进一步防止这些性能恶化。本发明涉及一种金属医疗器械，其表面至少部分经过可聚合硅烷化合物 A 和含有官能团的可聚合化合物 B 的共聚物 C 的处理。
• Metal medical device
  申请人：SUMITOMO RUBBER INDUSTRIES, LTD.

  公开号：US10092680B2

  公开（公告）日：2018-10-09

  The present invention provides metal medical devices which are provided with sliding properties (lubricity), low protein adsorption properties and low cell adsorption properties and further in which these properties are prevented from deteriorating. The present invention relates to a metal medical device having a surface at least partially treated with a copolymer C of a polymerizable silane compound A and a polymerizable compound B that contains a functional group.

  本发明提供的金属医疗器械具有滑动性能（润滑性）、低蛋白吸附性能和低细胞吸附性能，并能进一步防止这些性能恶化。本发明涉及一种金属医疗器械，其表面至少部分经过可聚合硅烷化合物 A 和含有官能团的可聚合化合物 B 的共聚物 C 的处理。
• Agglutination accelerator for immunological measurement
  申请人：WAKO PURE CHEMICALS INDUSTRIES, LTD.

  公开号：US20040157276A1

  公开（公告）日：2004-08-12

  An object of the present invention is to provide an immunoassay of PSA using an agglutination accelerator, which has an agglutination accelerating effect equal to or stronger than the known agglutination accelerator; hardly generates non-specific turbidity; and hardly generates salting out even in a solution with a high salt concentration. The present invention relates to an immunoassay of a prostate-specific antigen comprising performing an antigen-antibody reaction in the presence of a polymer having a monomer unit derived from a monomer represented by the following general formula [2]: 1 (wherein R 1 -R 3 are each independently a hydrogen atom or an alkyl group optionally having a hydroxyl group; R 4 is an alkylene group; R 5 is an alkylene group optionally having a substituent and optionally having an oxygen atom in a chain; R 6 is a hydrogen atom or a methyl group, and X is an oxygen atom or a —NH— group), and a kit of reagent for an immunoassay comprising a reagent containing an agglutination accelerator for the immunoassay.

  本发明的目的是提供一种使用凝集加速剂的前列腺特异性抗原免疫测定方法，其凝集加速效果等于或强于已知的凝集加速剂；几乎不产生非特异性浑浊；即使在高浓度盐溶液中也几乎不产生盐析。本发明涉及一种前列腺特异性抗原的免疫测定方法，它包括在一种聚合物存在的情况下进行抗原-抗体反应，该聚合物具有从由下列通式[2]表示的单体衍生而来的单体单元： 1 (其中 R 1 -R 3 各自独立地为氢原子或可选带有羟基的烷基；R 4 是亚烷基 5 是一个亚烷基，可选择带有一个取代基，并可选择在链中带有一个氧原子；R 6 是氢原子或甲基，X 是氧原子或-NH-基团)，以及免疫测定试剂盒，该试剂盒包含用于免疫测定的凝集促进剂。